At this stage of the Covid pandemic... and vaccination rates in the US are starting to drop a bit due to the younger crowds not getting the vaccine and males (in certain states) refusing the vaccine, we may be in COVID for a few more years.
If vaccinations rates tick up due to those groups getting the vaccination... plus boosters for variants and the current vaccine... we might be out of this faster. The 1st scenario is more plausible at this point in time.
With that said... IF this is a successful drug... what portion of the market COULD ZOFIN serve? What are the middle and best case scenarios? I'm trying to figure that out - which depends on it being successfully adopted in the 1st place. What is the sales potential for this company?
I added a significant amount of shares today. I could be wrong, but I think now is the time to buy if it's going anywhere. Otherwise, we will just drift into r/s and dilution land.
Thoughts?
News 
Market Data 
Discover 
